The CHG index is positively associated with MASLD risk in type 2 diabetes patients aged 50 and older, a relationship partially mediated by immunoinflammatory markers NAR, NLR, and SII.
Is the CHG index associated with MASLD risk in patients with T2DM aged ≥50 years?
The CHG index, mediated by immunoinflammatory markers, may have potential application in diagnosing MASLD in older patients with type 2 diabetes.
Absolute Event Rate: 0% vs 0%
The CHG index was positively associated with MASLD risk in patients with T2DM aged ≥50 years. NAR, NLR, and SII partially mediated this association, highlighting their potential application in MASLD diagnosis.
Pan et al. (Wed,) reported a other. The CHG index is positively associated with MASLD risk in type 2 diabetes patients aged 50 and older, a relationship partially mediated by immunoinflammatory markers NAR, NLR, and SII.